Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Uwe Schwarzwälder
,
Thomas Zeller
Added:
3 years ago
The first renal artery balloon angioplasties were performed by Felix Mahler in Berne and Andreas Grüntzig in Zurich in 1977 using self-made, bulky, coaxial balloon catheters.1,2 Until the beginning of the 1990s, balloon angioplasty was the only method of percutaneous treatment of renal artery stenosis (RAS) with satisfying acute and long-term results for angioplasty of stenoses caused by…
View more
Author(s):
William R Colyer Jr
,
Christopher J Cooper
Added:
3 years ago
Renal artery stenosis (RAS) is a common manifestation of atherosclerotic disease. Although the exact prevalence rate for the population as a whole is unknown, RAS is seen in a significant proportion of patients who present with another manifestation of atherosclerosis (Table 1).1–7 Despite this high degree of prevalence, the management of RAS, specifically the role of revascularisation, remains…
View more
Author(s):
Martin G Radvany
Added:
3 years ago
Catheter-based vascular interventions continue to evolve as new devices continue to expand the capabilities of interventionalists and improve patient safety. The importance of athero-embolisation during vascular intervention has long been recognised.1 Embolic protection devices (EPDs) were developed to help prevent embolisation during endovascular procedures. The risk of distal embolisation is…
View more
Author(s):
Brock Cookman
,
Suhail Allaqaband
,
Tonga Nfor
Added:
3 years ago
With an ageing population, the burden of peripheral artery diseases (PADs) is increasing. The treatment of these diseases has largely been performed by interventional radiologists, vascular surgeons and interventional cardiologists. In 2011, the percentage of procedures performed per specialty were 12.9 %, 45.0 % and 42.2 % for interventional radiology, vascular surgery and interventional…
View more
Foreword
Author(s):
Jeffrey W Moses
Added:
3 years ago
Article
Author(s):
Bernard Schieffer
Added:
4 years ago
Author(s):
Katrina Mountfort
Added:
3 years ago
Hypertension is one of the most important public health problems of the 21st century, with a global prevalence of around 30 %.1 In 2010, it accounted for 7.5 million deaths worldwide, representing 12.8 % of the global total.2 Furthermore, its prevalence is projected to rise to 1.5 billion hypertensive patients in 2025.3 Despite the availability of numerous safe and effective antihypertensive…
View more
Author(s):
Roland Schmieder
,
Michel Burnier
,
Cara East
,
et al
Added:
1 year ago
Author(s):
Vikas Kapil
,
Ajay K Jain
,
Melvin D Lobo
Added:
3 years ago
Up to one-in-five treated hypertensive patients are deemed to be treatment resistant1-3 (on at least three different anti-hypertensive medication classes, including a diuretic)4-6 and have high cardiovascular risk.7-9 There is a paucity of high-quality evidence to suggest that the addition of a fourth line (or fifth, sixth line, etc.) medication is likely to bring either hypertension under…
View more